🔎 Trials Near Me

홈 › 만성 폐쇄성 폐질환 › 루이지애나

루이지애나의 만성 폐쇄성 폐질환 임상 시험

만성 폐쇄성 폐질환 관련 연구 10개가 루이지애나 내 여러 지역에서 참여자를 모집하고 있습니다.

루이지애나의 도시

공식 연구 텍스트(영어)

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

  • GSK Investigational Site, Lake Charles
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07780669

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

  • Care Access Research - Shreveport, Shreveport
피험자 모집 중2상
40세 ~ 85세 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07684820

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Zachary
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083, Shreveport
  • Care Access - Shreveport - Youree Drive- Site Number : 8400007, Shreveport
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 23. 업데이트됨 · NCT07190222

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Southern Clinical Research, LLC, Zachary
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07363694

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Southern Clinical Research - Zachary- Site Number : 8400113, Zachary
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07190209

STRIVE Post-Market Registry Study

  • LSU Health Shreveport, Shreveport
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 16. 업데이트됨 · NCT04302272

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Baton Rouge
  • GSK Investigational Site, Lafayette
  • GSK Investigational Site, Shreveport
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06961214

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Lafayette
  • Research Site, Monroe
  • Research Site, Shreveport
  • 외 1개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06283966

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Lake Charles
  • GSK Investigational Site, Shreveport
피험자 모집 중3상
40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.